Ampio Pharmaceuticals, Inc. (AMPE)

The momentum for this stock is not very good. Ampio Pharmaceuticals, Inc. (AMPE) is not a good growth stock. Ampio Pharmaceuticals, Inc. (AMPE) is not very popular among insiders. Ampio Pharmaceuticals, Inc. (AMPE) is a mediocre stock to choose.
Log in to see more information.
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of thera...
AMPE Fundamental Data by TradingView

News

Ampio Pharmaceuticals Announces Reverse Stock Split
Ampio Pharmaceuticals Announces Reverse Stock Split

PR Newswire Ampio Pharmaceuticals Announces Reverse Stock Split Ampio Pharmaceuticals Announces Reverse Stock Split PR Newswire ENGLEWOOD, Colo., Aug. 31, 2023 ENGLEWOOD, Colo., Aug. 31, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the 'Company') today announced that its...\n more…

Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock
Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

PR Newswire Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock PR Newswire ENGLEWOOD, Colo., May 26, 2023 ENGLEWOOD, Colo., May 26, 2023 /PRNewswire/ -- Ampio...\n more…

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS
AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

PR Newswire AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS PR Newswire ENGLEWOOD, Colo., April 18, 2023 ENGLEWOOD, Colo., April 18, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the 'Company') today released the...\n more…